In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal Statistics, Q4 2012

A look at financing, M&A, and alliance activity, October – December 2012

Executive Summary

Device firms closed the final quarter of 2012 with $1.1 billion in financing, led by Volcano’s debt offering. Takeovers of Gambro and PSS Medical topped the device M&A list. At $196 million, Q4 diagnostic financing was the lowest quarter of the year, but IPOs returned with three public debuts. Amgen’s $415 million acquisition of deCODE was the largest diagnostic M&A.

Advertisement

Related Content

Baxter Acquires Gambro, Becomes Integrated Renal Therapy Leader
Renal Denervation Land Grab Continues As Boston Scientific Buys Vessix
MorphoSys Finds Right Time To Focus On Pipeline With AbD Serotec Sale To Bio-Rad Labs
Wright Medical Augments Ortho Extremities Biz With BioMimetic Purchase
Stryker M&A Strategy Intact Under New CEO With Latest Deal For Stroke Care
The Renal Denervation Buzz: Separating Fact From Myth; Covidien Buys Maya Medical
Renal Denervation: Device Market’s Gold Rush

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV004013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel